COMMUNIQUÉS West-GlobeNewswire

Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform
30/04/2026
Kriya’s integrated R&D and manufacturing platform is designed to make gene therapies accessible for more common chronic diseases ASGCT presentations reflect Kriya’s commitment to continuously optimize its platform [...]
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
30/04/2026
Commencement of activities in international markets is supported by the successful completion of the Limited Market Release, followed by the Recent Full Market Release in the U.S. Strong physician interest at recent [...]
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
30/04/2026
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion clinical [...]
Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months
30/04/2026
Ramat Gan, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the [...]
AVITA Medical Names Cary Vance as Chief Executive Officer
30/04/2026
Board appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and thorough search process by the Board Jan Stern Reed elected as Chair of the AVITA Medical Board VALENCIA, Calif., [...]
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
30/04/2026
Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension despite medication at [...]
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
30/04/2026
CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced [...]
A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine
30/04/2026
Supports scientific development and laboratory testing to advance pharmacogenomics deployment across Japan TOKYO, April 30, 2026 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare [...]
Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research
30/04/2026
The collaboration expands Precision's clinical research network, deepening investigation into AI-driven neural cursor control and neuroprosthetics NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
30/04/2026
CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data [...]
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
30/04/2026
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized [...]
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
30/04/2026
In-Vivo Ovine Study Demonstrates Sustained Performance Of Company’s Continuous Blood Glucose Monitoring (CBGM) Technology Over 240 Days, Reinforces Path to Key IDE Submission RUTHERFORD, N.J., April 30, 2026 (GLOBE [...]
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
30/04/2026
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
30/04/2026
— The new pricing structure is made available as of February for 12,67 PLN per day at pharmacies throughout Poland AMSTERDAM, April 30, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical [...]
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment
30/04/2026
Appointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, function-preserving treatment options CHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) -- Sonablate, a medical [...]
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
30/04/2026
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision [...]
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
30/04/2026
DENVER, April 30, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or the “Company”), a leading developer of recombinant spider silk-based fibers, has achieved [...]
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
30/04/2026
Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence [...]
Living Carbon secures $500m deal with Octopus Energy Generation to restore degraded land and remove CO₂
30/04/2026
This comes as Octopus’ fund management team also injects an additional $13 million in the scale-up’s carbon business SAN FRANCISCO, U.S. / LONDON, UK, April 30, 2026 (GLOBE NEWSWIRE) -- Living Carbon PBC, a climate [...]

Pages